Background: In lung transplantation surgery, extracorporeal life support (ECLS) is essential for safety. Various support methods, including cardiopulmonary bypass (CPB) and off-pump techniques, are used, with extracorporeal membrane oxygenation (ECMO) gaining prominence. However, consensus on the best support strategy is lacking.
Purpose: This article reviews risks, benefits, and outcomes of different support strategies in lung transplantation. By consolidating knowledge, it aims to clarify selecting the most appropriate ECLS modality.
Research Design: A comprehensive literature review examined CPB, off-pump techniques, and ECMO outcomes in lung transplantation, including surgical results and complications.
Study Sample: Studies, including clinical trials and observational research, focused on ECLS in lung transplantation, both retrospective and prospective, providing a broad evidence base.
Data Collection and/or Analysis: Selected studies were analyzed for surgical outcomes, complications, and survival rates associated with CPB, off-pump techniques, and ECMO to assess safety and effectiveness.
Results: Off-pump techniques are preferred, with ECMO increasingly vital as a bridge to transplant, overshadowing CPB. However, ECMO entails hidden risks and higher costs. While safer than CPB, optimizing ECMO postoperative use and monitoring is crucial for success.
Conclusions: Off-pump techniques are standard, but ECMO's role is expanding. Despite advantages, careful ECMO management is crucial due to hidden risks and costs. Future research should focus on refining ECMO use and monitoring to improve outcomes, emphasizing individualized approaches for LT recipients.
HuCXChenWHHeJX, et al.Lung transplantation in China between 2015 and 2018. Chin Med J2019; 132(23): 2783–2789.
2.
PerchMHayesDJr.CherikhWS, et al.The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-ninth adult lung transplantation report-2022; focus on lung transplant recipients with chronic obstructive pulmonary disease. J Heart Lung Transplant2022; 41(10): 1335–1347.
3.
GottliebJSmitsJSchrammR, et al.Lung transplantation in Germany since the introduction of the lung allocation score. Dtsch Arztebl Int2017; 114(11): 179–185.
4.
KiziltugHFalterF. Circulatory support during lung transplantation. Curr Opin Anaesthesiol2020; 33(1): 37–42.
5.
Di NardoMTikkanenJHusainS, et al.Postoperative management of lung transplant recipients in the intensive care unit. Anesthesiology2022; 136(3): 482–499.
6.
HayangaJWAChanEGMusgroveK, et al.Extracorporeal membrane oxygenation in the perioperative care of the lung transplant patient. Semin CardioThorac Vasc Anesth2020; 24(1): 45–53.
7.
HoechterDJShenYMKammererT, et al.Extracorporeal circulation during lung transplantation procedures: a meta-analysis. Asaio j2017; 63(5): 551–561.
8.
HoetzeneckerKSchwarzSMuckenhuberM, et al.Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation. J Thorac Cardiovasc Surg2018; 155(5): 2193–2206.e2193.
9.
HashimotoKHoetzeneckerKYeungJC, et al.Intraoperative extracorporeal support during lung transplantation in patients bridged with venovenous extracorporeal membrane oxygenation. J Heart Lung Transplant2018; 37(12): 1418–1424.
10.
SalmanJIusFSommerW, et al.Mid-term results of bilateral lung transplant with postoperatively extended intraoperative extracorporeal membrane oxygenation for severe pulmonary hypertension. Eur J Cardio Thorac Surg2017; 52(1): 163–170.
11.
TakaHMiyoshiKKurosakiT, et al.Lung transplantation via cardiopulmonary bypass: excellent survival outcomes from extended criteria donors. Gen Thorac Cardiovasc Surg2019; 67(7): 624–632.
12.
YavariMBeckerRC. Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass. J Thromb Thrombolysis2009; 27(1): 95–104.
13.
DykeCMSmediraNGKosterA, et al.A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. J Thorac Cardiovasc Surg2006; 131(3): 533–539.
14.
WelshKJNedelcuEBaiY, et al.How do we manage cardiopulmonary bypass coagulopathy?Transfusion2014; 54(9): 2158–2166.
15.
BermudezCAShioseAEsperSA, et al.Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation. Ann Thorac Surg2014; 98(6): 1936–1942, ; discussion 1942-1933.
16.
Shore-LessersonLBakerRAFerrarisV, et al.STS/SCA/AmSECT clinical practice guidelines: anticoagulation during cardiopulmonary bypass. J Extra Corpor Technol2018; 50(1): 5–18.
17.
AljureODFabbroM2nd. Cardiopulmonary bypass and inflammation: the hidden enemy. J Cardiothorac Vasc Anesth2019; 33(2): 346–347.
18.
BronickiRAHallM. Cardiopulmonary bypass-induced inflammatory response: pathophysiology and treatment. Pediatr Crit Care Med2016; 17(8 Suppl 1): S272–278.
19.
BoodramSEvansE. Use of leukocyte-depleting filters during cardiac surgery with cardiopulmonary bypass: a review. J Extra Corpor Technol2008; 40(1): 27–42.
20.
MagouliotisDETasiopoulouVSSvokosAA, et al.Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a meta-analysis. Gen Thorac Cardiovasc Surg2018; 66(1): 38–47.
21.
LoorGHuddlestonSHartwigM, et al.Effect of mode of intraoperative support on primary graft dysfunction after lung transplant. J Thorac Cardiovasc Surg2022; 164(5): 1351–1361.e1354.
Sequential bilateral lung transplantation for paraquat poisoning. A case report. The Toronto Lung Transplant group. J Thorac Cardiovasc Surg. 1985;89(5):734-742.
24.
ZapolWMSniderMTHillJD, et al.Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA1979; 242(20): 2193–2196.
25.
JurmannMJHaverichADemertzisS, et al.Extracorporeal membrane oxygenation (ECMO): extended indications for artificial support of both heart and lungs. Int J Artif Organs1991; 14(12): 771–774.
26.
GlassmanLRKeenanRJFabrizioMC, et al.Extracorporeal membrane oxygenation as an adjunct treatment for primary graft failure in adult lung transplant recipients. J Thorac Cardiovasc Surg1995; 110(3): 723–726, ; discussion 726-727.
27.
NguyenDQKulickDMBolmanRM3rd, et al.Temporary ECMO support following lung and heart-lung transplantation. J Heart Lung Transplant2000; 19(3): 313–316.
28.
AignerCWisserWTaghaviS, et al.Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardio Thorac Surg2007; 31(3): 468–473, ; discussion 473-464.
29.
FuehnerTKuehnCHademJ, et al.Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med2012; 185(7): 763–768.
30.
HakimAHAhmadUMcCurryKR, et al.Contemporary outcomes of extracorporeal membrane oxygenation used as bridge to lung transplantation. Ann Thorac Surg2018; 106(1): 192–198.
31.
KimNEWooAKimSY, et al.Long- and short-term clinical impact of awake extracorporeal membrane oxygenation as bridging therapy for lung transplantation. Respir Res2021; 22(1): 306.
RandoHJFanningJPChoSM, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation: practice patterns and patient outcomes. J Heart Lung Transplant2023; 43(1): 77–84.
34.
ShafiiAEMcCurryKR. Subclavian insertion of the bicaval dual lumen cannula for venovenous extracorporeal membrane oxygenation. Ann Thorac Surg2012; 94(2): 663–665.
35.
HoetzeneckerKDonahoeLYeungJC, et al.Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center. J Thorac Cardiovasc Surg2018; 155(3): 1316–1328.
36.
IusFNatanovRSalmanJ, et al.Extracorporeal membrane oxygenation as a bridge to lung transplantation may not impact overall mortality risk after transplantation: results from a 7-year single-centre experience. Eur J Cardio Thorac Surg2018; 54(2): 334–340.
YanagidaRSeethamrajuHDavenportDL, et al.Bridging to lung transplantation with double-lumen venovenous extracorporeal membrane oxygenation. Int J Artif Organs2019; 42(11): 621–627.
39.
GulackBCHirjiSAHartwigMG. Bridge to lung transplantation and rescue post-transplant: the expanding role of extracorporeal membrane oxygenation. J Thorac Dis2014; 6(8): 1070–1079.
40.
GlorionMMercierOMitilianD, et al.Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension. Eur J Cardio Thorac Surg2018; 54(2): 341–347.
41.
BonicoliniEMartucciGSimonsJ, et al.Limb ischemia in peripheral veno-arterial extracorporeal membrane oxygenation: a narrative review of incidence, prevention, monitoring, and treatment. Crit Care2019; 23(1): 266.
42.
AbramsDGaranARBrodieD. Awake and fully mobile patients on cardiac extracorporeal life support. Ann Cardiothorac Surg2019; 8(1): 44–53.
43.
ChicotkaSRosenzweigEBBrodieD, et al.The "central sport model": extracorporeal membrane oxygenation using the innominate artery for smaller patients as bridge to lung transplantation. Asaio j2017; 63(4): e39–e44.
44.
SinghSKD'OvidioFGaranAR, et al.Minimally invasive central venoarterial extracorporeal membrane oxygenation for long-term ambulatory support as a bridge to heart-lung transplant. J Artif Organs2020; 23(4): 394–396.
45.
ForoutanFMalikAClarkKE, et al.Predictors of 1-year mortality after adult lung transplantation: systematic review and meta-analyses. J Heart Lung Transplant2022; 41(7): 937–951.
46.
MattarAChatterjeeSLoorG. Bridging to lung transplantation. Crit Care Clin2019; 35(1): 11–25.
47.
HayangaJWAHayangaHKHolmesSD, et al.Mechanical ventilation and extracorporeal membrane oxygenation as a bridge to lung transplantation: closing the gap. J Heart Lung Transplant2019; 38(10): 1104–1111.
48.
LeeJGKimNNarmKS, et al.The effect of additional stepwise venous inflow on differential hypoxia of veno-arterial extracorporeal membrane oxygenation. Asaio j2020; 66(7): 803–808.
49.
ZangrilloALandoniGBiondi-ZoccaiG, et al.A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc2013; 15(3): 172–178.
50.
RuszelNKiełbowskiKPiotrowskaM, et al.Central, peripheral ECMO or CPB? Comparsion between circulatory support methods used during lung transplantation. J Cardiothorac Surg2021; 16(1): 341.
51.
MazzeffiMGreenwoodJTanakaK, et al.Bleeding, transfusion, and mortality on extracorporeal life support: ECLS working group on thrombosis and hemostasis. Ann Thorac Surg2016; 101(2): 682–689.
52.
SklarMCSyELequierL, et al.Anticoagulation practices during venovenous extracorporeal membrane oxygenation for respiratory failure. A systematic review. Ann Am Thorac Soc2016; 13(12): 2242–2250.
53.
CernakVOude Lansink-HartgringAvan den HeuvelER, et al.Incidence of massive transfusion and overall transfusion requirements during lung transplantation over a 25-year period. J Cardiothorac Vasc Anesth2019; 33(9): 2478–2486.
54.
SzetoWYKreiselDKarakousisGC, et al.Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome. J Thorac Cardiovasc Surg2002; 124(2): 241–249.
55.
de BoerWJHepkemaBGLoefBG, et al.Survival benefit of cardiopulmonary bypass support in bilateral lung transplantation for emphysema patients. Transplantation2002; 73(10): 1621–1627.
56.
DalibonNGeffroyAMoutafisM, et al.Use of cardiopulmonary bypass for lung transplantation: a 10-year experience. J Cardiothorac Vasc Anesth2006; 20(5): 668–672.
57.
ScaravilliVMorlacchiLCMerrinoA, et al.Intraoperative extracorporeal membrane oxygenation for lung transplantation in cystic fibrosis patients: predictors and impact on outcome. J Cyst Fibros2020; 19(4): 659–665.
58.
CosterJNNodaKRyanJP, et al. Effects of intraoperative support strategies on endothelial injury and clinical lung transplant outcomes. Semin Thorac Cardiovasc Surg2023. S1043-0679(23)00001-1.
59.
PrekkerMENathDSWalkerAR, et al.Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant2006; 25(4): 371–378.
60.
KawutSMOkunJShimboD, et al.Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation. Chest2009; 136(1): 237–244.
61.
DiamondJMLeeJCKawutSM, et al.Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med2013; 187(5): 527–534.
62.
RaphaelJCollinsSRWangXQ, et al.Perioperative statin use is associated with decreased incidence of primary graft dysfunction after lung transplantation. J Heart Lung Transplant2017; 36(9): 948–956.
63.
BurdettCButtTLordanJ, et al.Comparison of single lung transplant with and without the use of cardiopulmonary bypass. Interact Cardiovasc Thorac Surg2012; 15(3): 432–436, ; discussion 436.
64.
MohitePNSabashnikovAPatilNP, et al.The role of cardiopulmonary bypass in lung transplantation. Clin Transplant2016; 30(3): 202–209.
65.
CerianaPKlersyCVeronesiR, et al.Influence of underlying lung disease on early postoperative course after single lung transplantation. J Cardiovasc Surg2002; 43(5): 715–722.
66.
PadiaSABorjaMCOrensJB, et al.Tracheostomy following lung transplantation predictors and outcomes. Am J Transplant2003; 3(7): 891–895.
67.
FerrerJRodriguezERomanA, et al.Factors related to postoperative mortality in lung transplantation for emphysema. Transplant Proc2007; 39(10): 3317–3322.
68.
CassiviSDMeyersBFBattafaranoRJ, et al.Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg2002; 74(5): 1663–1669, ; discussion 1669-1670.
69.
MachucaTNSchioSMCamargoSM, et al.Prognostic factors in lung transplantation: the Santa Casa de Porto Alegre experience. Transplantation2011; 91(11): 1297–1303.
70.
SekineYWaddellTKMatte-MartynA, et al.Risk quantification of early outcome after lung transplantation: donor, recipient, operative, and post-transplant parameters. J Heart Lung Transplant2004; 23(1): 96–104.
71.
WeingartenNSchraufnagelDPlittG, et al.Comparison of mechanical cardiopulmonary support strategies during lung transplantation. Expet Rev Med Dev2020; 17(10): 1075–1093.
72.
MachucaTNCollaudSMercierO, et al.Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg2015; 149(4): 1152–1157.
73.
HoechterDJvon DossowVWinterH, et al.The Munich Lung transplant group: intraoperative extracorporeal circulation in lung transplantation. Thorac Cardiovasc Surg2015; 63(8): 706–714.
74.
Dell'AmoreACampisiACongiuS, et al.Extracorporeal life support during and after bilateral sequential lung transplantation in patients with pulmonary artery hypertension. Artif Organs2020; 44(6): 628–637.
75.
BiscottiMYangJSonettJ, et al.Comparison of extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg2014; 148(5): 2410–2415.
76.
IusFSommerWTudoracheI, et al.Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: indications and midterm results. J Heart Lung Transplant2016; 35(1): 49–58.
77.
NosottiMPalleschiARossoL, et al.Clinical risk factors for primary graft dysfunction in a low-volume lung transplantation center. Transplant Proc2014; 46(7): 2329–2333.
78.
HoetzeneckerKBenazzoAStorkT, et al.Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: an observational study. J Thorac Cardiovasc Surg2020; 160(1): 320–327.
79.
LiLJXuHYWangXW, et al. Impact of delayed veno-venous extracorporeal membrane oxygenation weaning on postoperative rehabilitation of lung transplantation: a single-center comparative study. J Artif Organs2022; 26(4): 303–308.
80.
IusFKuehnCTudoracheI, et al.Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg2012; 144(6): 1510–1516.
81.
PettenuzzoTFaggiGDi GregorioG, et al.Blood products transfusion and mid-term outcomes of lung transplanted patients under extracorporeal membrane oxygenation support. Prog Transplant2018; 28(4): 314–321.
82.
XiaYRagalieWYangEH, et al.Venoarterial versus venovenous extracorporeal membrane oxygenation as bridge to lung transplantation. Ann Thorac Surg2022; 114(6): 2080–2086.
83.
BiscottiMBacchettaM. The "sport model": extracorporeal membrane oxygenation using the subclavian artery. Ann Thorac Surg2014; 98(4): 1487–1489.
84.
NarmKSLeeSSuhJW, et al.Risk factor analysis for intraoperative extracorporeal membrane oxygenation weaning failure after lung transplantation. Ann Thorac Surg2018; 105(1): 242–248.
85.
TakahashiTTeradaYPasqueMK, et al.Outcomes of extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation. Ann Thorac Surg2023; 115(5): 1273–1280.
86.
RoyerPJOlivera-BotelloGKoutsokeraA, et al.Chronic lung allograft dysfunction: a systematic review of mechanisms. Transplantation2016; 100(9): 1803–1814.
87.
MartinuTPavliskoENChenDF, et al.Acute allograft rejection: cellular and humoral processes. Clin Chest Med2011; 32(2): 295–310.
88.
Moffatt-BruceSDKaramichalisJRobbinsRC, et al.Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?Ann Thorac Surg2006; 81(1): 286–291, ; discussion 291.
